15/01/2016
Parc Tecnològic del Vallès: Arrival of FERRER and Accreditation of SEVIBE CELLS
Parc Tecnològic del Vallès: Arrival of FERRER and Accreditation of SEVIBE CELLS
The Parc Tecnològic del Vallès (PTV) is the oldest technology park in Spain (1987). PTV can be considered as the initial phase of a more global project of a territory designed to attract innovative companies in the environment of the Universitat Autònoma de Barcelona. This project has matured with the second phase corresponding to the creation of the Barcelona Synchrotron Park (BSP) around the ALBA synchrotron operative since 2012.
With 133 companies (2,760 employees, total turnover of 845 million euros), PTV recently received two good news from the healthcare sector:
On one hand, FERRER pharmaceutical multinational company has started activities in PTV with the creation of a research center devoted to new technologies for medication administration.
On the other hand, SEVILLE CELLS, which is already settled in PTV, has received the AABB accreditation (American Association of Blood Banks) and therefore becomes the 5th blood and tissue bank among the 117 banks in Europe (the first one in Spain) to be internationally certified for cell therapy. It can be mentioned that the FAMICORD European group to which SEVIBE CELLS belongs already carried out 127 cord blood stem cells transplants, making it the leader in Europe.
With 133 companies (2,760 employees, total turnover of 845 million euros), PTV recently received two good news from the healthcare sector:
On one hand, FERRER pharmaceutical multinational company has started activities in PTV with the creation of a research center devoted to new technologies for medication administration.
On the other hand, SEVILLE CELLS, which is already settled in PTV, has received the AABB accreditation (American Association of Blood Banks) and therefore becomes the 5th blood and tissue bank among the 117 banks in Europe (the first one in Spain) to be internationally certified for cell therapy. It can be mentioned that the FAMICORD European group to which SEVIBE CELLS belongs already carried out 127 cord blood stem cells transplants, making it the leader in Europe.
More news
28/01/2021
Institutional visit to the Elena Renewable Gas Plant in Parc de l'Alba
12/01/2021
2021: the Alba synchrotron begins its mutation
30/12/2020
The Park has a new Urban Development Master Plan
29/11/2020
The director of Parc de l'Alba, Pere Solà, academic director of the new Postgraduate Course in Urban Planning and Health at the UPC School
18/11/2020
Catalan minister Ramon Tremosa visits the ALBA synchrotron and announces the creation of a public-private investment fund to improve knowledge transfer
03/11/2020
Catalonia, at the forefront of Europe in life sciences and health; the Alba synchrotron contributes to this leadership